The consistent reduction in amplitude and T1/2 of response reported in this current investigation suggests that TRPM3 dysfunction reported in ME/CFS patients impairs sufficient Ca2+ entry in NK cells. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.